# Wacker Biotech US

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wacker-biotech-us

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.wacker.com/biologics
- Total disclosed funding: $7.2M
- Latest round: Series B (Jun 15, 2020)
- Investors on record: 1

## About

Founded in 2018 and based in San Diego, US, Wacker Biotech US Inc., formerly known as Genopis Inc., operates as a biopharmaceutical company that offers contract development and manufacturing services for drugs and various treatments. In June 2020, Genopis Inc. raised Series B funding from investor Medivate Partners. Later In February 2021, Wacker Chemie agreed to acquire a full ownership stake in Genopis Inc. for USD 42 million. 

The company offers a range of services, including molecular biology, process development, analytical development, and GMP manufacturing of biologics. The company engages in the biologics industry, providing services for the development and manufacturing of biopharmaceutical products and solutions for various sectors like pharmaceuticals and food additives.

## Funding rounds

- Series B, Jun 15, 2020 — LINEA Investment
- Series A, Sep 28, 2018, $7.2M — LINEA Investment

## Investors

- LINEA Investment (https://capitalatlas.ai/funds/linea-investment) — Series A, Series B